Continuing Education Activity

Medial epicondylitis, commonly known as golfer’s elbow, is an overuse injury that occurs from tendinosis of the medial elbow at the origin of the flexor-pronator muscle group. A corticosteroid injection may be indicated when first-line therapies such as activity modification, bracing, analgesics, and physical therapy have failed. This activity reviews the evaluation and treatment of medial epicondylitis via corticosteroid injection and highlights the interprofessional team's role in coordinating appropriate care of this condition.

Objectives:

• Review elbow anatomy at the medial epicondyle.
• Outline the presentation and common physical exam findings of a patient with medial epicondylitis and indications for a medial epicondyle injection.
• Summarize the procedure details for a medial epicondyle injection.
• Describe the importance of collaboration and communication amongst the interprofessional team to enhance care coordination for patients receiving medial epicondyle injections.

Introduction

Tendinosis is a frequent cause of elbow pain, both in athletes and the general population, and is a result of overuse. Medial epicondylitis, commonly known as golfer’s elbow or little leaguer's elbow, represents tendinosis of the medial elbow at the origin of the flexor-pronator muscle group (see Images. Golfer's Elbow, Medial Elbow Anatomy). The tendons most commonly involved in medial epicondylitis include the pronator teres and flexor carpi radialis. 

The medial epicondyle is on the distal humerus outside of the elbow joint capsule. It serves as the origin of the ulnar collateral ligament, pronator teres, and the common flexor tendon. The common flexor tendon includes the tendons of the flexor carpi radialis, flexor carpi ulnaris, flexor digitorum superficialis, and the palmaris longus. It provides stability against both valgus and flexion forces.[1] The ulnar collateral ligament is the primary restraint to valgus instability and is composed of anterior, posterior, and transverse bundles. The ulnar nerve runs posteriorly to the medial epicondyle in the ulnar groove and within the cubital tunnel.[2] See Image. Left Elbow Joint, Anterior and Internal Ligaments.

Etiology

Overuse, specifically repetitive forearm pronation and wrist flexion, results in degenerative changes of the flexor and pronator tendons at their origin on the medial epicondyle. While uncommon, trauma or sudden eccentric contraction of the wrist flexors can result in an acute presentation of medial epicondylitis.[2]

Epidemiology

Research has found the prevalence of medial epicondylitis in working-aged adults to be between 0.4 to 0.6%.[3][4] A study examining medial epicondylitis in the United States military population reported an incidence rate of 0.81 per 1000 person-years.[5] While it may occur in all age groups, it is most prevalent in the fourth and fifth decades of life and most frequently involves the dominant arm. It affects men and women equally. Medial epicondylitis is less prevalent than lateral epicondylitis and represents less than 20% of all epicondylitis diagnoses.[6] Occupations requiring repetitive upper extremity movements, especially repetitive bending and straightening of the elbow, are associated with an increased risk of medial epicondylitis. Sports that require repetitive valgus stress and flexion at the elbow, such as golf, baseball, and bowling, increase the risk of the development of medial epicondylitis.[4]

Pathophysiology

Epicondylitis is an inaccurate term, as this condition does not represent acute inflammation of the bone. Instead, it is chronic tendinopathy of the flexor-pronator mass at its origin on the medial epicondyle. The condition occurs from recurrent microtrauma secondary to repetitive wrist flexion and pronation or repetitive valgus stress and flexion at the elbow. The flexor carpi radialis and pronator teres are the tendons most commonly involved.[6]

Histopathology

Histopathology reveals angiofibroblastic proliferation or collagen matrix disorganization with the development of neovessels.[2] Partial or full-thickness tears can occur as a part of the degenerative process.

History and Physical

Medial epicondylitis presents with a gradual onset of pain along the medial elbow that is worse with activity. Symptoms are often mild and intermittent but can be severe, resulting in significant pain and disability. The examination reveals tenderness along the medial epicondyle and proximal pronator and flexor tendons. Patients experience pain during resisted wrist flexion and pronation and during passive terminal wrist extension. These provocative maneuvers should be performed with the elbow fully extended. In more chronic cases, patients may experience a loss of wrist extension range of motion. There may be a decrease in grip strength.[6] 

In cases of isolated medial epicondylitis, the ulnar collateral ligament and ulnar nerve should not be tender. A valgus stress test to assess the ulnar collateral ligament should be performed without instability or worsened pain. Ulnar neuritis is assessable by cubital tunnel compression testing and Tinel sign. A careful neurological examination, including 2-point discrimination testing of the fifth digit, is also necessary to assess the ulnar nerve. There is a high association of ulnar neuropathy with medial epicondylitis, occurring concomitantly in 60% of cases.[7]

Evaluation

Medial epicondylitis is a clinical diagnosis and does not require imaging. X-rays may be useful for evaluating recalcitrant cases and for ruling out other pathologies. MRI and ultrasound can visualize tendinosis, but are not required for diagnosis.

Treatment / Management

The initial management of epicondylitis is conservative. Nonoperative treatment is successful in more than 95% of patients. When treated with observation alone, symptoms persist between 6 months and 2 years.[8][9] First-line therapies include rest, ice, analgesics, bracing, and physical therapy. Relative rest and activity modification are key components to resolution and are required in both athletes and the general population for at least 6 weeks. During the early stages, when acute inflammation may be present, ice, compression, and elevation may provide benefits. As the condition evolves into chronic tendinosis, these therapies are less likely to be effective. Non-steroidal anti-inflammatory drugs (NSAIDs) are a common choice for pain relief despite limited evidence on their effectiveness. A Cochrane review demonstrated low-quality evidence for short-term pain relief with topical NSAIDs, while results for oral NSAIDs have been inconclusive.[10]

Bracing typically employs a counterforce strap applied just distal to the elbow joint to minimize the strain applied on the tendon origin at the medial epicondyle. Patients treated with a counterforce brace show improvement in pain and function compared to physical therapy at 6 weeks, but no difference after 26 weeks. Volar wrist splints are a method for immobilizing the wrist and limiting flexor activity.  While wrist splints may reduce pain, they should be reserved for severe cases, as they may prolong symptom duration.[11] Physical therapy includes rehabilitation programs aimed at strengthening and improving flexibility. It also provides modalities for soft-tissue mobilization. When used in isolation or as adjunctive therapy, eccentric exercises improve function and grip strength and reduce pain.[12]

Topical glyceryl trinitrate patches may stimulate collagen synthesis and play a role in healing tendons. When used alongside physical therapy, patients demonstrated improvements in both pain and function, with 81% reporting no symptoms at 6 months.[13] A medial epicondyle corticosteroid injection merits consideration in patients with symptoms refractory to other conservative measures or for those presenting with severe symptoms. Corticosteroid injections result in short-term pain relief (less than 12 weeks).[14] Autologous blood and platelet-rich plasma (PRP) injections may result in improvements in the intermediate-term (12 to 26 weeks) compared to corticosteroids.[15] However, low-quality studies and conflicting results prevent routine recommendations for PRP or autologous blood injections.[16] Both prolotherapy and botulinum toxin A injections result in reductions in pain compared to placebo, but are not more effective than corticosteroid injections.[14]

Surgical intervention is rarely necessary but is a consideration in cases with severe pain or marked dysfunction that is refractory to conservative treatments after 6 months or in cases persisting for longer than 12 months.

Differential Diagnosis

Medial epicondylitis requires differentiation from other causes of pain along the medial aspect of the elbow. This includes ulnar nerve entrapment, ulnar nerve subluxation, ulnar collateral ligament insufficiency, osteoarthritis, little league elbow, osteochondritis dissecans, and posteromedial elbow impingement.[17]

Treatment Planning

Indications for Medial Epicondyle Injection

Corticosteroids are the most common type of injection used for medial epicondylitis and are typically reserved for cases refractory to initial non-operative treatments after 6 to 12 weeks. Injections may also be used earlier in the course of the disease if symptoms are severe.   

Contraindications

Contraindications to a medial epicondyle injection include cellulitis or other infection overlying or around the area, allergies to corticosteroid or anesthetic agents, local malignancy, skin breakdown, or fracture at the site of injection. In patients with diabetes mellitus, poorly controlled diabetes with hyperglycemia is an additional contraindication. There is no threshold for the number of injections that can be administered; however, multiple injections are not recommended, and injections are usually limited to 1.

Equipment

• 5 mL syringe
• 25-gauge, 1-inch needle
• 2 mL of anesthetic agent
• 1 mL corticosteroid (methylprednisolone, dexamethasone, and triamcinolone are common agents used. The provider may choose his or her preferred corticosteroid as there is no data to support 1 steroid type or dose.)[14]
• Gloves
• Chlorhexidine, alcohol pads, or other skin cleaning solution
• Topical anesthetic spray (optional)

Personnel

Physicians, physician assistants, or nurse practitioners trained in this procedure can perform the injection. A medical assistant, nurse, athletic trainer, or other assistants may be used to prep the patient.

Preparation

The provider discusses the procedure's risks and benefits and obtains written informed consent. A time-out to identify the patient, the procedure, and the site should be performed before the procedure.

Technique

The patient is placed in the supine position with the arm abducted and supinated. The point of maximal tenderness is palpated over the medial epicondyle and may be marked by indenting the skin with the tip of a pen or the capped needle. The injection site is then cleaned with chlorhexidine. An assistant may apply a topical anesthetic spray to the area if desired. Using an aseptic technique, the needle is inserted directly down to the level of bone, then withdrawn 1 to 2 mm before slowly injecting the anesthetic and corticosteroid solution. Ultrasound guidance has not demonstrated improved clinical outcomes compared to blinded techniques.[18][19]

A peppering technique that involves needle insertion with multiple small injections performed by retracting and repositioning without withdrawing the needle from the skin is also an option. Multiple passes are made until the clinician no longer feels crepitus while passing the needle. This minor fenestration of the tendon causes bleeding and inflammation, which may stimulate a healing response.

Toxicity and Adverse Effect Management

Corticosteroids have anti-inflammatory properties and can modify the body's immune response. The most feared complication of corticosteroid injections is acute infection resulting from immunosuppression. With proper adherence to aseptic technique, this complication is exceedingly rare. Common complications of the procedure include skin atrophy or hypopigmentation at the site. Some patients may have a paradoxical increase in pain for the first 24 hours after the injection. Increased pain that lasts for several days after the procedure is a rare complication known as a "steroid flare." In patients with diabetes mellitus, it is imperative to note blood glucose levels before and after corticosteroid injection to prevent severe hyperglycemic episodes.

Prognosis

There is a paucity of data on the outcomes of injections for medial epicondylitis, and much of the evidence used to guide treatment has been extrapolated from studies of lateral epicondylitis. Despite the absence of inflammation, corticosteroids are likely effective in relieving pain of neurogenic origin. Corticosteroids are effective in improving short-term pain relief.  However, there is a high recurrence of pain and lack of benefit demonstrated at 1 year compared to observation and physical therapy. Therefore, corticosteroid injections should only be performed concurrently with other non-operative therapies.[20] Comparisons of a single injection of corticosteroid or a peppered injection of corticosteroid have shown more favorable results with the peppered technique.[21][22]

Complications

Complications of medial epicondyle injection may include:

• Transient vasovagal reaction
• Bleeding
• Infection
• Acute worsening of pain
• Skin and fat atrophy
• Ulnar nerve damage
• Worsening of the degeneration of the tendon
• Worsened pain and function after 3 months [23]

Deterrence and Patient Education

Patients should receive advice regarding relative rest following a medial epicondyle corticosteroid injection. Patients should understand the possibility of a steroid flare that can acutely worsen the pain; this is treatable with ice, acetaminophen, and NSAIDs. Following an injection, patients should continue with activity modifications and other therapies until the pain subsides.  A session on proper mechanics should take place before returning to work or sports. A slow functional progression of sport-specific exercises is required for a successful return to play.  Typically, activity modifications and treatment are necessary for a total period of 6 to 12-weeks. 

Enhancing Healthcare Team Outcomes

Medial epicondylitis is a chronic condition that can negatively impact function and cause significant pain. Initial treatment is conservative and requires multiple healthcare team members, including the clinical provider, nurses, medical assistants, athletic trainers, pharmacists, and physical therapists, to provide education, bracing, medications, and rehabilitation.

To improve healthcare outcomes, it is essential to have a functioning, cohesive interprofessional team, especially if a medial epicondyle injection is planned. Clinical providers should communicate the treatment plan to the specialty nurses, pharmacists, and physical therapists to achieve this goal. The pharmacists' role in these cases involves a thorough evaluation of the patient's medication profile and prior treatments to identify potential interactions or adverse reactions. By communicating these findings to the medical team, the pharmacist can help reduce adverse reactions in these patients. The specialty nurse plays a crucial role in educating patients about post-procedural restrictions and monitoring, particularly for patients with diabetes mellitus. By identifying patients at the highest risk of complications, the nurse can help focus the healthcare team's resources on those areas where they would be most effective. The physical therapist needs to alter the treatment plan once a medical epicondyle corticosteroid injection is given. The medical provider must communicate this to the physical therapist to ensure that appropriate therapy is delivered.

Review Questions

• Access free multiple choice questions on this topic.
• Click here for a simplified version.
• Comment on this article.

References

1.

Kheterpal AB, Bredella MA. Overuse Injuries of the Elbow. Radiol Clin North Am. 2019 Sep;57(5):931-942. [PubMed: 31351542]

2.

Pitzer ME, Seidenberg PH, Bader DA. Elbow tendinopathy. Med Clin North Am. 2014 Jul;98(4):833-49, xiii. [PubMed: 24994055]

3.

Shiri R, Viikari-Juntura E, Varonen H, Heliövaara M. Prevalence and determinants of lateral and medial epicondylitis: a population study. Am J Epidemiol. 2006 Dec 01;164(11):1065-74. [PubMed: 16968862]

4.

Walker-Bone K, Palmer KT, Reading I, Coggon D, Cooper C. Occupation and epicondylitis: a population-based study. Rheumatology (Oxford). 2012 Feb;51(2):305-10. [PMC free article: PMC3427015] [PubMed: 22019808]

5.

Wolf JM, Mountcastle S, Burks R, Sturdivant RX, Owens BD. Epidemiology of lateral and medial epicondylitis in a military population. Mil Med. 2010 May;175(5):336-9. [PubMed: 20486505]

6.

Taylor SA, Hannafin JA. Evaluation and management of elbow tendinopathy. Sports Health. 2012 Sep;4(5):384-93. [PMC free article: PMC3435941] [PubMed: 23016111]

7.

Hariri S, McAdams TR. Nerve injuries about the elbow. Clin Sports Med. 2010 Oct;29(4):655-75. [PubMed: 20883903]

8.

Smidt N, Lewis M, VAN DER Windt DA, Hay EM, Bouter LM, Croft P. Lateral epicondylitis in general practice: course and prognostic indicators of outcome. J Rheumatol. 2006 Oct;33(10):2053-59. [PubMed: 16881095]

9.

Struijs PA, Kerkhoffs GM, Assendelft WJ, Van Dijk CN. Conservative treatment of lateral epicondylitis: brace versus physical therapy or a combination of both-a randomized clinical trial. Am J Sports Med. 2004 Mar;32(2):462-9. [PubMed: 14977675]

10.

Pattanittum P, Turner T, Green S, Buchbinder R. Non-steroidal anti-inflammatory drugs (NSAIDs) for treating lateral elbow pain in adults. Cochrane Database Syst Rev. 2013 May 31;2013(5):CD003686. [PMC free article: PMC7173751] [PubMed: 23728646]

11.

Meissner A, Vives MI, Román J, Meissner A. Is wrist splint more effective than forearm band for lateral epicondylitis? Medwave. 2017 Dec 28;17(9):e7124. [PubMed: 29286358]

12.

Cullinane FL, Boocock MG, Trevelyan FC. Is eccentric exercise an effective treatment for lateral epicondylitis? A systematic review. Clin Rehabil. 2014 Jan;28(1):3-19. [PubMed: 23881334]

13.

McCallum SD, Paoloni JA, Murrell GA. Five-year prospective comparison study of topical glyceryl trinitrate treatment of chronic lateral epicondylosis at the elbow. Br J Sports Med. 2011 Apr;45(5):416-20. [PubMed: 19553221]

14.

Sims SE, Miller K, Elfar JC, Hammert WC. Non-surgical treatment of lateral epicondylitis: a systematic review of randomized controlled trials. Hand (N Y). 2014 Dec;9(4):419-46. [PMC free article: PMC4235906] [PubMed: 25414603]

15.

Houck DA, Kraeutler MJ, Thornton LB, McCarty EC, Bravman JT. Treatment of Lateral Epicondylitis With Autologous Blood, Platelet-Rich Plasma, or Corticosteroid Injections: A Systematic Review of Overlapping Meta-analyses. Orthop J Sports Med. 2019 Mar;7(3):2325967119831052. [PMC free article: PMC6419259] [PubMed: 30899764]

16.

Ahmad Z, Brooks R, Kang SN, Weaver H, Nunney I, Tytherleigh-Strong G, Rushton N. The effect of platelet-rich plasma on clinical outcomes in lateral epicondylitis. Arthroscopy. 2013 Nov;29(11):1851-62. [PubMed: 24060428]

17.

Donaldson O, Vannet N, Gosens T, Kulkarni R. Tendinopathies Around the Elbow Part 2: Medial Elbow, Distal Biceps and Triceps Tendinopathies. Shoulder Elbow. 2014 Jan;6(1):47-56. [PMC free article: PMC4986646] [PubMed: 27582910]

18.

Gulabi D, Uysal MA, Akça A, Colak I, Çeçen GS, Gumustas S. USG-guided injection of corticosteroid for lateral epicondylitis does not improve clinical outcomes: a prospective randomised study. Arch Orthop Trauma Surg. 2017 May;137(5):601-606. [PubMed: 28258434]

19.

Malahias MA, Kaseta MK, Kazas ST, Megaloikonomos PD, Mavrogenis AF, Babis GC. Image-guided versus palpation-guided injections for the treatment of chronic lateral epicondylopathy: a randomized controlled clinical trial. Handchir Mikrochir Plast Chir. 2018 Sep;50(5):348-352. [PubMed: 30404123]

20.

Ciccotti MC, Schwartz MA, Ciccotti MG. Diagnosis and treatment of medial epicondylitis of the elbow. Clin Sports Med. 2004 Oct;23(4):693-705, xi. [PubMed: 15474230]

21.

Dogramaci Y, Kalaci A, Savaş N, Duman IG, Yanat AN. Treatment of lateral epicondilitis using three different local injection modalities: a randomized prospective clinical trial. Arch Orthop Trauma Surg. 2009 Oct;129(10):1409-14. [PubMed: 19219442]

22.

Okçu G, Erkan S, Sentürk M, Ozalp RT, Yercan HS. Evaluation of injection techniques in the treatment of lateral epicondylitis: a prospective randomized clinical trial. Acta Orthop Traumatol Turc. 2012;46(1):26-9. [PubMed: 22441448]

23.

Olaussen M, Holmedal O, Lindbaek M, Brage S, Solvang H. Treating lateral epicondylitis with corticosteroid injections or non-electrotherapeutical physiotherapy: a systematic review. BMJ Open. 2013 Oct 29;3(10):e003564. [PMC free article: PMC3816235] [PubMed: 24171937]

Disclosure: Kimbre Zahn declares no relevant financial relationships with ineligible companies.

Disclosure: Doug Byerly declares no relevant financial relationships with ineligible companies.